Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Immune Related Adverse Events With CD24Fc (TIRAEC)

NCT04552704 is registered in ClinicalTrials.gov with Tianhong Li as lead sponsor.

NCT NCT04552704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04552704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Immune Related Adverse Events With CD24Fc (TIRAEC)
Lead sponsor
Tianhong Li
Phase
Phase 1/2
Overall status
Terminated
Start date
October 30, 2020
Completion date
January 26, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm